Skip to main content
Log in

Extremely Elevated CA19-9 in Acute Cholangitis

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

A 68-year-old women was admitted with the chief complaints of epigastralgia with radiation to the back and jaundice. Fever and chills were also noted. The laboratory data showed alkaline phosphatase, 245 U/L (normal range: 28–94); Direct Bilirubin, 5.29 mg% (0–0.4); Total Bilirubin, 8.4 mg% (0.2–1.4). Surprisingly, the serum CA19-9 was 5673.8 U/ml (normal value: <37). Abdominal sonography showed dilated common hepatic duct. MRCP demonstrated diffuse biliary tree dilatation with a very low signal intensity in distal common bile duct. Surgical intervention reveled a black stone at distal common bile duct and was successfully retrieved. After operation, the CA19-9 fell to 63.1 u/ml two weeks later and returned to normal (10.4 U/ml) one month later.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Koprowski H, Steplewski Z, Mitchell K, et al. (1981) Specific antigen in serum of patients with colon carcinoma. Science 212:53–55

    Article  PubMed  CAS  Google Scholar 

  2. Savarinu V (1984) Evaluation of a new tumor-antigen in pancreatic cancer. Digestion 22:1–5

    Google Scholar 

  3. Yoshikawa T, Nishida K, Tanigawa M, et al. (1985) Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancy. Digestion 31:67–76

    Article  PubMed  CAS  Google Scholar 

  4. Arends JW, Verstynen C, Bosman FT, et al. (1983) Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissue: an immunoperoxidase study. Hybridoma 2:219–229

    Article  PubMed  CAS  Google Scholar 

  5. McFarlane IG (1983) Hepatic clearance of serum glycoproteins. Clin Sci 64:127–135

    PubMed  CAS  Google Scholar 

  6. Steinberg WM (1990) The clinical utility of the CA19-9 tumor-associated antigen. Am J Gastroenterol 85:350–355

    PubMed  CAS  Google Scholar 

  7. Changchien CS, Yung CY, Tzen KY (1991) Serum CEA and CA 19-9 value in patients with pancreatic cancer or pancreatitis. Chang Gung Med J 14:32–38

    Google Scholar 

  8. Craxi A, Patti C, Aragona E (1985) Serum CA19-9 levels in patients with hepatocellular carcinoma or cirrhosis. Ital J Gastroenterol 17:288–289

    Google Scholar 

  9. Tolliver BA, O’Brien BL (1997) Elevated tumor-associated antigen CA19-9 in a patient with an enlarged pancreas: does it always imply malignancy? Southern Med J 90:89–90

    CAS  Google Scholar 

  10. Kim HJ, Kim MH, Myung SJ, et al. (1999) A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using receive operating characteristic curve. Am J Gastroenterol 94:1941–1946

    Article  PubMed  CAS  Google Scholar 

  11. Murohisa T, Sugaya H, Tetsuka I, et al. (1992) A case of common bile duct stone with cholangitis presenting an extraordinary high serum CA19-9 value. Int Med 31:516–520

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shyr-Ming Sheen-Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sheen-Chen, SM., Sun, CK., Liu, YW. et al. Extremely Elevated CA19-9 in Acute Cholangitis. Dig Dis Sci 52, 3140–3142 (2007). https://doi.org/10.1007/s10620-006-9164-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9164-7

Keywords

Navigation